Jay Achar

11 works

Médecins sans Frontières, Manson Unit, London, UK

1. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   ArticleTuberculosis Research and EpidemiologyBMC Medicine20163 citations

   ABIABI:AkademIndex/openalex/2026.other.195695

2. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Nell Gray +5

   ArticleTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 citations

   ABIABI:AkademIndex/openalex/2026.other.195708

3. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   ArticleTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 citations

   ABIABI:AkademIndex/openalex/2018.article.000181

4. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   ArticleTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 citations

   ABIABI:AkademIndex/openalex/2019.article.000020

5. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   ArticleTuberculosis Research and EpidemiologyERJ Open Research20201 citations

   ABIABI:AkademIndex/openalex/2026.other.360284

6. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   ArticleTuberculosis Research and EpidemiologyPLoS ONE20201 citations

   ABIABI:AkademIndex/openalex/2026.other.360285

7. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

   Jay Achar, Catherine Berry, Krzysztof Herboczek +7

   OtherTuberculosis Research and EpidemiologyEmerging infectious diseases20150 citations

   ABIABI:AkademIndex/openalex/2015.other.000001

8. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

   Horacio Gil, Hasmik Margaryan, I. Azamat +8

   ArticleTuberculosis Research and EpidemiologyTropical Medicine & International Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.003743

9. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

   Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

   PreprintTuberculosis Research and EpidemiologySSRN Electronic Journal20240 citations

   ABIABI:AkademIndex/openalex/2024.preprint.000046

10. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

    Michael L. Rekart, Phone Thit, Modupe Oluya +14

    Review articleTuberculosis Research and EpidemiologyIJTLD OPEN20240 citations

    ABIABI:AkademIndex/openalex/2024.review-article.000146

11. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

    Review articleTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 citations

    ABIABI:AkademIndex/openalex/2025.review-article.000036